☆ 4.0 Article

Outcomes of Dual Versus Triple Antiretroviral Drug Regimens Among Virally Suppressed Adults in the DC Cohort

AIDS RESEARCH AND HUMAN RETROVIRUSES (2022)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV

Ramon Teira et al.

Summary: The study compared real-world outcomes of INSTI-based triple therapy with DTG- and/or bPI-based 2DC in a large Spanish cohort of HIV patients. Patients on INSTI-based TT had significantly higher time to discontinuation and probability of remaining free of virologic failure compared to those on DTG- and/or bPI-containing 2DC, with no differences in toxicity.

PLOS ONE (2021)

Add to Collection

Article Immunology

Efficacy and safety of dolutegravir-rilpivirine for maintenance of virological suppression in adults with HIV-1:100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies

Michael Aboud et al.

LANCET HIV (2019)

Add to Collection

Article Medicine, General & Internal

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn et al.

LANCET (2019)

Add to Collection

Article Immunology

Two-drug antiretroviral regimens: an assessment of virologic response and durability among treatment-experienced persons living with HIV in the OPERA® Observational Database

Gerald Pierone et al.

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2019)

Add to Collection

Review Virology

HIV drug resistance against strand transfer integrase inhibitors

Kaitlin Anstett et al.

RETROVIROLOGY (2017)

Add to Collection

Article Computer Science, Information Systems

Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions

Alan E. Greenberg et al.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2016)

Add to Collection

Outcomes of Dual Versus Triple Antiretroviral Drug Regimens Among Virally Suppressed Adults in the DC Cohort

Related references

Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV

Efficacy and safety of dolutegravir-rilpivirine for maintenance of virological suppression in adults with HIV-1:100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Two-drug antiretroviral regimens: an assessment of virologic response and durability among treatment-experienced persons living with HIV in the OPERA® Observational Database

HIV drug resistance against strand transfer integrase inhibitors

Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions

Export Citation

Share Paper